Sep 13, 2022 Earlier this month, the Icelandic biotech Alvotech received a response letter from FDA surrounding its potential interchangeable biosimilar ...
Jan 9, 2020 FDA investigators are trained to ensure that each observation noted on the FDA Form 483 is clear, specific and significant. Observations are ...
Staff-ups, manufacturing expansions and ambitious mRNA production projects in places like Africa have emerged at a rapid clip as CEO Uğur Şahin charts his quest
Sep 22, 2022 A US FDA Form 483 has revealed visible foreign particles in certain batches ... in vials produced by the contract development manufacturing ...
Catalent's Covid-19 vaccine manufacturing site hit with Form 483 over foreign objects in vials and other QC issues. Tyler Patchen. News Reporter. An Indiana-
Sep 5, 2022 If you're a medical device company manufacturing Class II or Class III devices, you can expect to have the FDA turning up for an inspection.
Nov 24, 2020 During an inspection, ORA investigators may observe conditions they deem to be objectionable. These observations, are listed on an FDA Form 483 ...
Jan 5, 2015 No medical device manufacturer wants to get a Form 483 or a Warning Letter from the FDA. However, if it does happen, manufacturers must take ...